PT - JOURNAL ARTICLE AU - Wang, Chen AU - Calle, Paul AU - Yan, Feng AU - Zhang, Qinghao AU - Fung, Kar-ming AU - Pan, Chongle AU - Tang, Qinggong TI - Percutaneous Nephrostomy Guidance by a Convolutional Neural Network Based Endoscopic Optical Coherence Tomography System AID - 10.1101/2024.02.06.24302404 DP - 2024 Jan 01 TA - medRxiv PG - 2024.02.06.24302404 4099 - http://medrxiv.org/content/early/2024/03/21/2024.02.06.24302404.short 4100 - http://medrxiv.org/content/early/2024/03/21/2024.02.06.24302404.full AB - Percutaneous nephrostomy (PCN) is a commonly used procedure for kidney surgeries. However, difficulties persist in precisely locating the PCN needle tip during its insertion into the kidney. Challenges for PCN needle guidance exist in two aspects: 1) Accurate tissue recognition, and 2) Renal blood vessel detection. In this study, we demonstrated an endoscopic optical coherence tomography (OCT) system for PCN needle guidance. Human kidney samples are utilized in the experiments. Different renal tissues including: 1) cortex, 2) medulla, 3) calyx, 4) fat, and 5) pelvis can be clearly distinguished based on their OCT imaging features. We conduct kidney perfusion experiments to mimic the renal blood flow. Our system can efficiently detect the blood flow in front of PCN needle using Doppler OCT function. To improve surgical guidance efficiency and alleviate the workload of radiologists, we employ convolutional neural network (CNN) methods to automate the procedure. Three CNN models including ResNet50, InceptionV3, and Xception were applied for tissue classification. All of them demonstrate promising prediction results, with InceptionV3 achieving the highest recognition accuracy of 99.6%. For automatic blood vessel detection, nnU-net was applied, and it exhibited intersection over unions (IoU) values of 0.8917 for blood vessel and 0.9916 for background.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by NIH 1P20GM135009-01A1, NSF OIA-2132161, NSF CAREER AWARD 2238648, R01DK133717, OSCTR pilot grant, HR19-092 Oklahoma Health Research Program, OSCTR pilot grant, and funds from University of Oklahoma.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of University of Oklahoma has reviewed and granted expedited approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.